• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS Back to Search Results
Model Number VTICMO12.6
Device Problem Inadequacy of Device Shape and/or Size (1583)
Patient Problems Corneal Decompensation (1790); Low Blood Pressure/ Hypotension (1914); Inflammation (1932); Blurred Vision (2137); Visual Disturbances (2140); Halo (2227); No Code Available (3191)
Event Date 12/13/2017
Event Type  Injury  
Manufacturer Narrative
This product is manufactured in the u.S.But not marketed in the u.S.(b)(4).
 
Event Description
The reporter indicated that the surgeon implanted a 12.6 mm vticmo12.6 implantable collamer lens, -17.0/+2.0/170 (sphere/cylinder/axis), into the patient's right eye (od) on (b)(6) 2017.On (b)(6) 2017 the lens was explanted.The surgeon notes the following: excessive vault, significant reduction of irido-corneal angles (ica), corneal decompensation, pigment dispersion, unreactive (fixed) pupil, glare/haloes, blurred vision, inflammation, and "choroidal detachment, severe hypotension." reporter states that hypotension is "being resolved" and "in fact the patient is very good.".
 
Manufacturer Narrative
A lens work order search was performed.No similar complaint type events were found.Returned product evaluation found the lens returned dry in a lens case/vial with clear surgical residue/debris on product.Visual inspection found no visible damage to lens.Measurement of the hydration found moisture content on a high level; but not exceeding limits.The overall lens diameter was then found out of tolerance.The lens sn: (b)(4) was a 12.6mm implantable lens that is 0.22mm larger than the theoretical; the tolerance is +/-0.20mm.Since the work order search did not find additional similar errors to this complaint event, it can be concluded that the oos condition is not likely due to manufacturing or packaging.(b)(4).
 
Manufacturer Narrative
Device evaluation: measurement of the hydration found the lens to be overhydrated.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPLANTABLE COLLAMER LENS (ICL)
Type of Device
PHAKIC INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer (Section G)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer Contact
cynthia thai
1911 walker avenue
monrovia, CA 91016
6263037902
MDR Report Key7300916
MDR Text Key101093336
Report Number2023826-2018-00281
Device Sequence Number1
Product Code MTA
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/31/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date03/31/2020
Device Model NumberVTICMO12.6
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/09/2018
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/31/2018
Initial Date FDA Received02/27/2018
Supplement Dates Manufacturer Received03/08/2018
05/07/2018
Supplement Dates FDA Received04/09/2018
05/07/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/21/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age44 YR
-
-